Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Change in Accured Expenses (2020 - 2025)

Bio Essence has reported Change in Accured Expenses over the past 6 years, most recently at -$306245.0 for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$306245.0 for Q4 2025, down 9853.03% from a year ago — trailing twelve months through Dec 2025 was -$302037.0 (down 250.69% YoY), and the annual figure for FY2025 was -$302037.0, down 250.69%.
  • Change in Accured Expenses for Q4 2025 was -$306245.0 at Bio Essence, down from $5513.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for BIOE hit a ceiling of $377931.0 in Q3 2021 and a floor of -$490796.0 in Q2 2021.
  • Median Change in Accured Expenses over the past 5 years was -$18.0 (2024), compared with a mean of -$30029.9.
  • Peak annual rise in Change in Accured Expenses hit 137725.0% in 2025, while the deepest fall reached 9853.03% in 2025.
  • Bio Essence's Change in Accured Expenses stood at -$337578.0 in 2021, then surged by 99.63% to -$1233.0 in 2022, then skyrocketed by 83.37% to -$205.0 in 2023, then soared by 1631.71% to $3140.0 in 2024, then plummeted by 9853.03% to -$306245.0 in 2025.
  • The last three reported values for Change in Accured Expenses were -$306245.0 (Q4 2025), $5513.0 (Q3 2025), and -$1287.0 (Q2 2025) per Business Quant data.